• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

New failed trials of intrathecal rituximab in PMS

July 9, 2021  

T25FW useful to identify early progression in MS

June 29, 2021  

COVID vaccination and anti-CD20s – an update

June 28, 2021  

Highlights from EAN 2021

June 22, 2021  

COVID-19 mortality in MS patients: a systematic review

June 1, 2021  

Anti-CD20 therapies – Mechanisms of action

May 25, 2021  

MS Clinics Network updates COVID vaccine guidance

May 3, 2021  

Are trial data generalizable to MS population?

April 27, 2021  

Few vaccine responders with fingolimod, ocrelizumab

April 23, 2021  

Early, effective MS treatment revisited

April 8, 2021  
Previous
16
17
18
19
20
Next

Browse by Topic

  • MS (444)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Ofatumumab 2026 – update on real-world effectiveness posted on September 22, 2026
  • CLINICAL CASES IN NEUROLOGY – A YOUNG WOMAN WITH MILD EARLY MS posted on September 17, 2026
  • Highlights of EAN 2026 – Part 2 posted on July 9, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions